Mallinckrodt plc MNK announced that it will initiate a new phase IV study on H.P. Acthar Gel. This multi-center, randomized, double blind, placebo-controlled study will further assess the efficacy of ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Facing “significant litigation and debt issues,” embattled Mallinckrodt is filing for bankruptcy protection. At the same time, the company unveiled new details of proposed settlements covering opioid ...

Mallinckrodt’s Acthar Gel is no stranger to controversy. Pricing critics, payers and the feds have all targeted the controversial hormone injection. But now, Medicaid is hitting Acthar where it hurts ...

You would think that if a US senator had it on good authority that Medicare was spending hundreds of millions of dollars on a drug that may not work, there would be an uproar. Especially if the drug ...

FDA approved, H.P. Acthar® Gel (repository corticotropin injection), an injectable therapy commonly used to treat lupus, is under investigation. The researchers aim to capture additional data to help ...

Infantile spasms are hard to diagnose, which can lead to treatment delays, according to the study authors. Children under age 2 with a rare disorder that causes spasms have frequent doctors’ visits ...

Please provide your email address to receive an email when new articles are posted on . Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and ...

For its investigation into H.P. Acthar Gel, CNN analyzed payment and prescription data from the Centers for Medicare & Medicaid Services. To calculate how much the Medicare Part D program has spent on ...

Two whistleblowers at a pharmaceutical company responsible for one of the largest drug price increases in US history said the company bribed doctors and their staffs to increase sales, according to ...